A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia

Background and objectives: In clinical practice, physicians often use once-weekly (QW) and biweekly (Q2W) dosing of epoetin alfa to treat anemia in patients with chronic kidney disease (CKD). Although the literature supports this practice, previous studies were limited by short treatment duration, l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pergola, Pablo E., Gartenberg, Gary, Fu, Min, Wolfson, Marsha, Rao, Sudhakar, Bowers, Peter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2009
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2774960/
https://ncbi.nlm.nih.gov/pubmed/19808215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03470509
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak